Evergen Biotechnologies

What Evergen Biotechnologies does

Evergen Biotechnologies is a privately held agricultural biotechnology distributor and technology holder focused on cattle reproductive management. Founded in 2000 by the late Dr. Xiangzhong "Jerry" Yang (杨向中), a University of Connecticut scientist known for cloning work, the company operates primarily out of China with a small coordination footprint in Connecticut. Evergen holds exclusive Chinese distribution rights for Genex (US) bovine semen, Conception (Canada) DG29 pregnancy diagnostics, and Shanghai JiSheng hormones, supplying all major Chinese dairy farms and processors including Yili, Modern Dairy, AustAsia, and Sino Farm. The company also developed proprietary industrial-scale sexed bovine embryo production via in vitro fertilization, combined with a pioneered liquid nitrogen surface vitrification method that has demonstrated a 41% pregnancy rate in field trials and is supported by two filed patents.

The company's business model is a mix of product distribution and services: revenue is generated by importing and reselling bovine semen doses, marketing and conducting pregnancy testing using the DG29 series, distributing animal reproduction hormones, and providing dairy farm management consulting that covers veterinary care, data analysis, nutrition, reproduction, and farm management. Go-to-market is exclusively direct B2B to enterprise dairy customers in a single geography (China), with no disclosed pricing. Underlying proprietary technology consists of the IVF-based sexed embryo production pipeline and the vitrification preservation method that enables transport of embryos at scale.

Evergen is a small organization (1-10 employees) with a portfolio-of-distribution-rights structure that depends on the continuity of its three core supplier partnerships. The proprietary embryo technology and patents constitute the main internal R&D asset, while distribution exclusivity and brand recognition built over two decades for Genex semen represent the commercial moat. Customer relationships are concentrated in a handful of major Chinese dairy groups, with limited documented diversification beyond that segment.

Name

Evergen Biotechnologies

Legal name

Evergen Biotechnologies

Website

https://evergen.com

Company type

Private

Founded year

2000

Operating status

Operating

Headcount range

1–10 employees

Short description

Evergen Biotechnologies is a privately held agricultural biotechnology distributor that holds exclusive China rights to Genex bovine semen, Conception DG29 pregnancy diagnostics, and Shanghai JiSheng hormones, supplying major Chinese dairy farms and processors and offering proprietary sexed bovine embryo technology and farm consulting.

Ownership category

akta.pro rank

Product category

Bovine Genetics

NAICS

All Other Animal Production (11299)

SIC

Agricultural Prod-Livestock & Animal Specialties (200), Agricultural Services (700)

akta.pro industry

PRIMARYAFAEACAD

Dairy Breeding & Genetics (AI, Embryo Transfer)

Agriculture & Food Production/Animal Production & Aquaculture/Dairy Cattle Farming

SECONDARYAFAEAJAL

Cloning & Advanced Reproductive Technologies Services

Agriculture & Food Production/Animal Production & Aquaculture/Animal Breeding & Genetics Services

SECONDARYAFAEAJAC

Genomic Testing & Genetic Evaluation Services

Agriculture & Food Production/Animal Production & Aquaculture/Animal Breeding & Genetics Services

SECONDARYAFAEAJAF

Nucleus Herd/Flock Breeding & Multiplier Stock Supply

Agriculture & Food Production/Animal Production & Aquaculture/Animal Breeding & Genetics Services

Keywords

• Bovine genetics distribution
• Animal reproduction technology
• Bovine pregnancy testing
• Cattle breeding products
• Dairy farm consulting

Headquarters

HQ city

Vernon Rockville

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Technology or R&D, Personnel, Marketing or Sales, Operations

Revenue model

1. Bovine Semen Distribution: Distribution and retail of Genex bovine semen in China. Evergen imports semen doses and distributes to dairy farms. First shipment of 5,000 doses imported in 2005.
2. Pregnancy Testing Services: Conducts bovine pregnancy testing, trains farm technicians, and markets DG29 product series with exclusive right in China
3. Hormone Distribution: Distribution of estrus synchronization and superovulation hormones from Shanghai JiSheng for animal use
4. Dairy Farm Consulting: Dairy farm management consultation services including veterinary care, data analysis, nutrition, reproduction, and farm management

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Core offering

Evergen Biotechnologies is the exclusive distributor in China of cattle genetics, pregnancy detection, and reproductive hormone products from international partners (Genex, Conception, Shanghai JiSheng), and provides dairy farm management consulting. The company also develops proprietary sexed bovine embryo production technology using in vitro fertilization and liquid nitrogen surface vitrification.

Product overview

Evergen Biotechnologies is a distributor and provider of cattle genetics products and services in China. The company operates as a portfolio of exclusive distribution rights and proprietary technologies, including: bovine semen and embryos (Genex), pregnancy detection products (DG29, DG BlueEyes, DG Milk from Conception of Canada), animal reproduction hormones (Shanghai JiSheng), and dairy farm management consulting services. Evergen also developed proprietary sexed bovine embryo production technology using in vitro fertilization and liquid nitrogen surface vitrification for preservation. The products are distributed exclusively in China to major dairy farms and processors including Yili, Modern Dairy, and AustAsia.

Differentiator

Problem solved

Functional benefit

Quantifiable outcome

• 41% pregnancy rate achieved with sexed bovine embryos in field trials

Named customers4 records

Segments1 record

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Three partnerships are on record, tiered core.

• Conception (Quebec, Canada)coreChannel Partner/ Reseller/ Distributor · 1 January 2013Conception is an agricultural technology company based in Quebec, Canada specializing in animal reproduction technologies including bovine pregnancy tests. Evergen holds exclusive rights in China for DG29 pregnancy testing products, DG BlueEyes, and DG Milk. Evergen conducts pregnancy testing, trains farm technicians, and markets DG29 product series in China.
• Genex (CRB)coreChannel Partner/ Reseller/ Distributor · 1 January 2003Genex is a world leading cattle breeding company based in Shawano, Wisconsin, USA. Evergen became China's sole distributor for bovine semen produced by Genex in 2003. In 2005, China opened to US semen and Evergen imported its first shipment of 5,000 doses. Evergen has created a brand name for Genex's semen in China and supplies all major dairy farms and processors.
• Shanghai JiSheng Science and Biotechnologies Co. Ltd.coreChannel Partner/ Reseller/ DistributorShanghai JiSheng produces estrus synchronization and superovulation hormones for animal use. Evergen distributes these hormones in their target markets. All hormones have passed rigorous testing and approval processes and are fully registered in China.

Scale indicators5 records

Recent moves5 records

Expansion highlights4 records

Direct peers

• ABS Global (Genus plc): World's largest bovine genetics business selling sexed and conventional semen, embryos, and reproductive services to commercial dairies globally — directly competes with Evergen's full reproductive package.
• Alta Genetics: Major global bovine genetics distributor offering dairy and beef semen, embryo programs, and reproductive services to commercial dairies — direct comp to Evergen's Genex distribution and embryo business.
• Semex Alliance: Canadian-based bovine genetics cooperative (close to Evergen's Conception partnership roots) offering dairy and beef semen, sexed semen, and reproductive solutions to dairies worldwide — direct product overlap.
• CRV: International cattle genetics cooperative providing semen, embryos, and dairy herd management solutions across multiple geographies — comparable product portfolio to Evergen across genetics and herd reproduction.
• Select Sires: US-based cattle genetics cooperative providing bovine semen, embryo programs, and reproductive services — directly comparable to Evergen's genetics distribution and reproductive management positioning.
• STgenetics (now part of URUS Group): Global bovine genetics leader with SexedULTRA sexed semen and reproductive technology — directly competes with Evergen's sexed embryo and bovine genetics product lines and serves the same dairy genetics market.
• Genex (a CRB / Cooperative Resources International business): Evergen's own principal supplier and a leading North American cattle genetics company; functions as both partner and direct peer in bovine AI genetics, semen distribution, and reproductive consulting.
• Conception (Ro-main Inc.): Quebec-based reproductive technology company that makes the DG29 blood pregnancy test that Evergen distributes; operates as both supplier and peer in bovine pregnancy diagnostics and reproductive biotech.

Broad incumbents

• IDEXX Laboratories: Dominant veterinary diagnostics company with livestock and cattle pregnancy/bovine testing products — adjacent to Evergen's DG29 pregnancy testing business and broader animal reproductive diagnostics.
• Zoetis: Global animal-health giant offering reproductive hormones, diagnostics, and genetic services across species — overlap with Evergen's hormone distribution and pregnancy diagnostics, but within a much broader pharma portfolio.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/evergen-biotechnologies-inc.

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Evergen Biotechnologies